Diagnose Prostate Cancer Early With Smart Diagnostic Method

Prostate cancer is one of the most common cancers in men. The definitive diagnosis of prostate cancer, which shows different symptoms according to its stage, is made by biopsy. Thanks to the Fusion Prostate Biopsy method, which is one of the latest technologies in this field, cancer cases are detected as soon as possible and recurrent biopsies are not required. Ali Fuat Atmaca from Memorial Ankara Hospital Urology Department gave information about prostate cancer and fusion prostate biopsy procedure.

Controls should not be neglected

Prostate is a gland that is found in every man and weighs 18-20 grams in young adult men. It is an organ located in the section after the bladder and surrounding this part of the urinary tract. One of the problems encountered with prostate is prostate cancer.

Prostate cancer, which has high treatment success when diagnosed at an early stage, usually does not show symptoms at the initial stage. For this reason, men with a family history of prostate cancer should have their annual prostate check-ups from the age of 40 and after the age of 50 in all cases.

Symptoms may vary

Symptoms of prostate cancer, which has a insidious character, vary according to stage. Prostate cancer usually does not progress very quickly in the early stage and does not show symptoms. However, some species can spread quickly and can be aggressive. Prostate cancer can lead to similar complaints with benign prostate enlargement in the early stages. Difficulty in urinating, frequent urination at night, intermittent urination, presence of blood in semen or urine, and advanced bone pain, which are usually symptoms of benign prostate enlargement, can be seen.

Definitive diagnosis is made by biopsy

Although PSA elevation in the blood may provide information about the cancer by finger rectal examination, the definitive diagnosis of prostate cancer is made by prostate biopsy. In the biopsy procedure, a sample is taken from the prostate tissue for pathological examination. In addition to classical prostate biopsy, fusion prostate biopsy technique has also been used in the diagnosis of prostate cancer in recent years.

Fusion prostate biopsy targets tumour and risk areas

Classical prostate biopsy applied to detect tumours in the prostate gland has begun to be replaced by fusion prostate biopsy in the light of technological developments. Today, the location and borders of the tumour in the prostate gland can be determined by MRI. In the presence of PSA elevation in the blood or suspicious findings in the examination, Multiparametric Prostate MRI is performed first. These MR images and prostate images obtained by ultrasonography are superimposed in three dimensions by means of a fusion biopsy device. In this way, the tumour foci detected by MRI are reached with ultrasonography and needle biopsies are taken from the target tissue. With these biopsies taken from the targeted areas, cancer is detected at a higher rate than classical biopsy. With fusion prostate biopsy, which is a diagnostic method targeting tumour and cancer risk areas, both delay in diagnosis and recurrent biopsies are not required. This procedure can be performed under both local anaesthesia and operating room conditions by putting the patient to sleep under general anaesthesia.

Prepared by the Medical Editorial Board. Our health library contents have been prepared for informational purposes only and with the scientific content on the registration date. For all your questions, concerns, diagnosis or treatment about your health, please consult your doctor or health institution.